For instance, ACSL1 is up-regulated in colorectal cancer and estrogen receptor (ER)-negative, ER-positive and HER2-positive breast cancer subtypes, and high ACSL1 expression in these patients’ tumor samples is linked to unfavorable prognosis [12, 16–19]. This evidence concerns the gene ACSL1 and breast carcinoma.